Diarrhoea of unknown cause: medical treatment in a stepwise manner Management of Idiopathic Diarrhoea Based on Experience of Step-Up Medical Treatment

被引:2
|
作者
Jansson-Rehnberg, Ann-Sofie [1 ]
Drewes, Asbjorn Mohr [2 ]
Sponheim, Jon [3 ]
Borgfelt, Christer [4 ]
Munch, Andreas [5 ]
Graf, Wilhelm [6 ]
Simren, Magnus [7 ]
Lindberg, Greger [8 ]
Hellstrom, Per M. [9 ,10 ]
机构
[1] Uppsala Univ Hosp, Ctr Palliat Care, Uppsala, Sweden
[2] Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Mech Sense, Aalborg, Denmark
[3] Natl Hosp Norway, Div Surg Inflammatory Med & Transplantat, Transplantat Med, Oslo Univ Hosp, Oslo, Norway
[4] Skane Univ Hosp, Dept Obstet & Gynaecol, Lund, Sweden
[5] Univ Hosp, Dept Gastrointestinal Med, Linkoping, Sweden
[6] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[7] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden
[8] Karolinska Univ Hosp, Dept Med, Huddinge, Sweden
[9] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[10] Uppsala Univ, Uppsala Univ Hosp, Dept Med Sci, bldg 40, 5th floor, Uppsala, Sweden
关键词
Absorption; cholestyramine; fiber; opioid; alpha2-receptor; IRRITABLE-BOWEL-SYNDROME; INTESTINAL TRANSIT; LOPERAMIDE; OCTREOTIDE; PATHOPHYSIOLOGY; CIPROFLOXACIN; ABSORPTION; DIAGNOSIS; RECEPTOR; CODEINE;
D O I
10.1080/00365521.2024.2313061
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The basic principle for the treatment of idiopathic diarrhoea (functional diarrhoea K59.1) is to delay transit through the gut in order to promote the absorption of electrolytes and water. Under mild conditions, bulking agents may suffice. With increasing severity, antidiarrhoeal pharmaceuticals may be added in a stepwise manner. In diarrhoea of unknown aetiology, peripherally-acting opioid receptor agonists, such as loperamide, are first-line treatment and forms the pharmaceutical basis of antidiarrheal treatment. As second-line treatment opium drops have an approved indication for severe diarrhoea when other treatment options fail. Beyond this, various treatment options are built on experience with more advanced treatments using clonidine, octreotide, as well as GLP-1 and GLP-2 analogs which require specialist knowledge the field.
引用
收藏
页码:543 / 546
页数:4
相关论文
共 50 条
  • [41] The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence”
    Rosario Pivonello
    Giorgio Arnaldi
    Carla Scaroni
    Carla Giordano
    Salvo Cannavò
    Davide Iacuaniello
    Laura Trementino
    Marialuisa Zilio
    Valentina Guarnotta
    Adriana Albani
    Alessia Cozzolino
    Grazia Michetti
    Marco Boscaro
    Annamaria Colao
    [J]. Endocrine, 2019, 64 : 657 - 672
  • [42] Cost-effectiveness analysis of the national implementation of integrated community case management and community-based health planning and services in Ghana for the treatment of malaria, diarrhoea and pneumonia
    Ferrer, Blanca Escribano
    Hansen, Kristian Schultz
    Gyapong, Margaret
    Bruce, Jane
    Bana, Solomon A. Narh
    Narh, Clement T.
    Allotey, Naa-Korkor
    Glover, Roland
    Azantilow, Naa-Charity
    Bart-Plange, Constance
    Sagoe-Moses, Isabella
    Webster, Jayne
    [J]. MALARIA JOURNAL, 2017, 16
  • [43] Implementation of an Enhanced "Step-Up" Approach Towards Early Tocilizumab for Management of Immune Checkpoint Inhibitor-Mediated Hepatotoxicity: A Case Study in Revisiting Paradigms of Treatment
    Zhang, Hao Chi
    Miller, Ethan
    Msaouel, Pavlos
    Wang, Lan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2357 - S2358
  • [44] Cost-effectiveness analysis of the national implementation of integrated community case management and community-based health planning and services in Ghana for the treatment of malaria, diarrhoea and pneumonia
    Blanca Escribano Ferrer
    Kristian Schultz Hansen
    Margaret Gyapong
    Jane Bruce
    Solomon A. Narh Bana
    Clement T. Narh
    Naa-Korkor Allotey
    Roland Glover
    Naa-Charity Azantilow
    Constance Bart-Plange
    Isabella Sagoe-Moses
    Jayne Webster
    [J]. Malaria Journal, 16
  • [45] Modafinil: its discovery, the early European and North American experience in the treatment of narcolepsy and idiopathic hypersomnia, and its subsequent use in other medical conditions
    Billiard, Michel
    Broughton, Roger
    [J]. SLEEP MEDICINE, 2018, 49 : 69 - 72
  • [46] Magnetic resonance imaging-based endovascular versus medical stroke treatment for symptom onset up to 12 h
    Wouters, Anke
    Lemmens, Robin
    Christensen, Soren
    Wilms, Guido
    Dupont, Patrick
    Mlynash, Michael
    Schneider, Armin
    Laage, Rico
    Cereda, Carlo W.
    Lansberg, Maarten G.
    Albers, Gregory W.
    Thijs, Vincent
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (01) : 127 - 133
  • [47] Changing proportion of patients with idiopathic dilated cardiomyopathy with SCDHeFT and CARE-HF/Companion characteristics during follow-up on optimal medical treatment
    Zecchin, M.
    Di Lenarda, A.
    Gregori, D.
    Pivetta, A.
    Merlo, M.
    Brun, F.
    Chicco, D.
    Sinagra, G.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 607 - 607
  • [48] The TraumaRegister DGUA® as the basis of medical quality management. Ten years experience of a national trauma centre exemplified by emergency room treatment
    Helm, M.
    Bitzl, A.
    Klinger, S.
    Lefering, R.
    Lampl, L.
    Kulla, M.
    [J]. UNFALLCHIRURG, 2013, 116 (07): : 624 - 632
  • [49] Adherence to AUA guidelines for the work-up, medical management, surgical evaluation and treatment of BPH: Work from a quality improvement collaborative
    Wahlstedt, Eric
    Graves, John Lee
    Wahlstedt, John
    D'Alessandro, Alison
    Cranford, Will
    Freidberg, Nicholas A.
    Bhalodi, Amul
    Bell, John R.
    James, Andrew
    Bylund, Jason
    Strup, Stephen E.
    Harris, Andrew
    [J]. LUTS-LOWER URINARY TRACT SYMPTOMS, 2024, 16 (04)
  • [50] Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission
    Sandborn, W. J.
    Feagan, B. G.
    Lichtenstein, G. R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (07) : 987 - 1003